Chargement en cours...
Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes
Progression-free survival (PFS) of patients with lower-risk myelodysplastic syndromes (MDS) treated with red blood cell transfusions is usually reduced, but it is unclear whether transfusion dose density is an independent prognostic factor. The European MDS Registry collects prospective data at 6-mo...
Enregistré dans:
| Publié dans: | Haematologica |
|---|---|
| Auteurs principaux: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Ferrata Storti Foundation
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7049377/ https://ncbi.nlm.nih.gov/pubmed/31171638 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2018.212217 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|